Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Pediatr. Sep 9, 2022; 11(5): 429-436
Published online Sep 9, 2022. doi: 10.5409/wjcp.v11.i5.429
Three novel homozygous ITGB2 mutations among two patients with leukocyte adhesion defect type-1: Two case reports
Yiwa Suksawat, Punchama Pacharn, Nunthana Siripipattanamongkol, Boonchai Boonyawat
Yiwa Suksawat, Division of Allergy and Immunology, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok 10400, Thailand
Punchama Pacharn, Division of Allergy and Immunology, Department of Pediatrics, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Nunthana Siripipattanamongkol, Division of Allergy and Immunology, Department of Pediatrics, Chiangrai Prachanukroh Regional Hospital, Chiangrai 57000, Thailand
Boonchai Boonyawat, Division of Medical Genetics, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok 10400, Thailand
Author contributions: Suksawat Y, Siripipattanamongkol N and Boonyawat B contributed to the drafting and writing of the case report manuscript and were involved in the clinical care of the patients; Boonyawat B extracted genomic DNA and performed genetic studies; Pacharn P supervised and edited the manuscript; all authors approved the final draft of the manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yiwa Suksawat, MD, Doctor, Division of Allergy and Immunology, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, 315 Rajavithi Road, Ratchathewi, Bangkok 10400, Thailand. yiwasuksawat@pcm.ac.th
Received: April 22, 2022
Peer-review started: April 22, 2022
First decision: May 31, 2022
Revised: June 10, 2022
Accepted: August 22, 2022
Article in press: August 22, 2022
Published online: September 9, 2022
Processing time: 138 Days and 6.6 Hours
Core Tip

Core Tip: Leukocyte adhesion defect (LAD) is a rare autosomal recessive primary immunodeficiency disorder characterized by defects in the leukocyte recruitment cascade. LAD type 1, caused by a mutation in ITGB2, is the most common form. Here, we report the first two cases of LAD type 1 with a molecularly confirmed ITGB2 mutation in Thailand. At the time of initial presentation, both patients had recurrent omphalitis, bacterial soft tissue infection, and marked leukocytosis. Molecular analysis revealed two missense variants and one nonsense mutation. Early identification of these patients by molecular analysis was proven essential for definitive diagnosis, proper antibiotic prophylaxis, and initiation of matched donor hematopoietic stem cell transplantation.